Picture of Atrion logo

ATRI Atrion Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual income statement for Atrion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue155148165184169
Cost of Revenue
Gross Profit70.766.269.475.962.4
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses115112129144147
Operating Profit40.535.73639.722.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes43.238.538.440.622.4
Provision for Income Taxes
Net Income After Taxes36.732.133.13519.4
Net Income Before Extraordinary Items
Extraordinary Items
Net Income36.832.133.13519.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income36.832.133.13519.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS19.717.418.219.611
Dividends per Share